About Jerrold Parker
Jerrold S. Parker is the founding partner of Parker Waichman LLP, a nationally recognized personal injury and mass tort law firm. With over 25 years of experience in personal injury litigation, he has built a distinguished career representing clients in complex personal injury, pharmaceutical, medical device, and mass tort cases. Before founding the firm in 1992, he served as a Special Agent in the Criminal Investigation Division of the U.S. Treasury Department's Internal Revenue Service from 1975 to 1983. He is also the creator of SmartAdvocate, a case management system for plaintiffs' personal injury law firms, and founded Innovative Legal Marketing.
He has been admitted to practice in all New York State courts, certain Columbia State courts, and New Jersey State courts. He has received a Five Dragon rating on Law Dragon (the highest rating possible), the Billion Dollar Trial Lawyers Award, a 10.0 Avvo Rating, and has been recognized in Best Lawyers in America 2026 for Mass Tort Litigation and Class Actions. He was selected to Super Lawyers from 2017 through 2024.
Proven verdicts and settlements at Parker Waichman LLP
These results are credited to Parker Waichman LLP. A result appears under an attorney's own name only when a published source names them as counsel on the case.
A Nassau County jury found on June 26, 2025 that South Shore Rehabilitation and Nursing Center in Freeport violated the Public Health Law and was negligent in caring for resident Henry Serrapica, who developed pressure ulcers on his heels, ankle and sacral area during 2019 and died that December. The jury awarded $5 million, including $1 million in punitive damages. In January 2026 the trial court denied the defense motions to set the verdict aside, reduce it or order a new trial, and the case then went to the Appellate Division.
A Richmond County jury awarded $1,102,000 to the family of a 73-year-old woman with Alzheimer's disease who fell at a Staten Island nursing facility and died weeks later; the Appellate Division reversed the judgment in 2020 and ordered a new trial.
In early 2014, Biomet agreed to pay at least $56 million to settle about 1,000 federal lawsuits over its M2a 38 and M2a Magnum metal-on-metal hip implants, consolidated in the Northern District of Indiana. Qualifying patients who had the device revised received a base award of $200,000, adjusted by individual factors. Thomas Anapol was court-appointed Co-Lead Counsel with W. Mark Lanier and signed the agreement for the Plaintiffs' Executive Committee. The figure covers many unrelated plaintiffs, is a reported minimum rather than a final total, and is not itemized by person.
Prior results do not guarantee a similar outcome. Each case is unique and depends on its own facts.
